Enginzyme develops enzyme immobilization technology for clean and efficient biomanufacturing as a self-described approach to meet sustainability goals in the chemical industry.

Robin Chatterjee

Samuel Hargestam

Karim Engelmark Cassimjee

Enginzyme

Debut Biotech is a biotechnology company that harnesses nature, science, and creativity to develop sustainable beauty products and cosmetic active ingredients through breakthrough technology and human-centered brand innovation.

Joshua Britton

Debut Biotech

Evolved By Nature is involved in peptide chemistry, creating molecules bioharvested from natural renewable resources to improve the performance and sustainability of consumer products such as skincare and textiles.

Evolved By Nature

Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the efficiency of the chemical industry in a best-of-both-worlds solution. EnginZyme is recognised as a Technology Pioneer by World Economic Forum and backed by Sofinnova Partners, Industrifonden, SEB Greentech VC, Bunge Ventures, Almi Invest GreenTech Fund, and Navigare Ventures.

Metric
Company Name	Enginzyme	Debut Biotech	Evolved By Nature
Symbol
MSH ID	COM:ENGINZYME	COM:DEBUTBIOTECH	COM:EVOLVEDBYNATURE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Consumer Goods
Industry	Biotechnology	Biotechnology	Biotechnology
Country	DE	US	US
Stage
Employee Count	57	85
Website	enginzyme.com	debutbiotech.com	evolvedbynature.com
LinkedIn		debutinnovation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		1.28K
Web Traffic Growth		-0.48
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ENGINZYME

Enginzyme

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue